Related Experiment Video

Updated: Jun 19, 2026

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation
09:53

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation

Published on: January 10, 2025

Anti-perforin neutralizing antibody reduces myocardial injury in viral myocarditis

Guo Chun-yan1, Han Bo, Chang Hong

  • 1Cardiology Division, Pediatric Department, Provincal Hospital affiliated to Shandong University, Shandong, Jinan, China.

Cardiology in the Young
|October 15, 2009
PubMed
Abstract

Insights

Anti-perforin neutralizing antibody therapy significantly reduced myocardial damage and apoptosis in viral myocarditis models. This suggests a promising therapeutic strategy by targeting the perforin/granzyme pathway and reducing caspase-3 expression.

Area of Science:

  • Immunology
  • Cardiology
  • Virology

Background:

  • Viral myocarditis is a serious condition often caused by coxsackie virus B3.
  • The perforin/granzyme pathway plays a role in viral-induced myocardial damage.
  • Caspase-3 is a key mediator of apoptosis in cardiomyocytes.

Purpose of the Study:

  • To investigate the therapeutic potential of anti-perforin neutralizing antibody in viral myocarditis.
  • To assess the effect of this antibody on myocardial damage, apoptosis, and caspase-3 expression.

Main Methods:

  • Balb/c mice were infected with coxsackie virus B3 and treated with anti-perforin neutralizing antibody.
  • Histopathology, TUNEL assay, immunohistochemistry, and RT-PCR were used to evaluate myocardial damage and apoptosis.
  • Viral titers and caspase-3 expression (protein and mRNA) were quantified.

Main Results:

  • Anti-perforin antibody treatment significantly reduced pathological scores, viral loads, and cardiomyocyte apoptosis.
  • Expression of active caspase-3 (protein and mRNA) was significantly downregulated in treated mice.
  • Caspase-3 expression and myocardial apoptosis were positively correlated with pathology scores.

Conclusions:

  • Anti-perforin neutralizing antibody effectively mitigates myocardial damage in viral myocarditis.
  • This therapeutic approach works by inhibiting the perforin/granzyme pathway and reducing caspase-3 activity.
  • Targeting perforin offers a promising novel strategy for treating viral myocarditis.

More Related Videos

Murine Myocardial Infarction Model using Permanent Ligation of Left Anterior Descending Coronary Artery08:38

Murine Myocardial Infarction Model using Permanent Ligation of Left Anterior Descending Coronary Artery

Published on: August 16, 2019

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...